Biomarker discovery study will be performed by exploration with a multiple screening platform with 1,310 different proteins, based on DNA aptamer technology (SOMAscan, Somalogic). These aptamers have been modified in their lateral chains, increasing their chemical diversity and, therefore, the number of targets. The whole library will be explored and, after the statistical analyses, the best candidates will be chosen for replication by simple ELISA.